ArticleActa pharmaceutica Sinica. B2023

A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-

Sae-Bom Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.